Preliminary data indicate that minocycline may be beneficial adjunct in the treatment of schizophrenia : positive , negative , and cognitive symptoms.In this study we aim to assess the efficacy of adjunctive minocycline to alleviate symptoms of schizophrenia in patients who have failed to respond to a therapeutic trial of antipsychotic medications .